Company Overview

Rhythm is a global, commercial-stage biopharmaceutical company committed to transforming the lives of patients and their families living with rare neuroendocrine diseases. We develop medicines for previously untreatable or undertreated diseases and provide meaningful support for healthcare providers and patients and their families. We recognize the courage it takes for patients and their caregivers to begin their journey of advocacy to find the answers they need. Their courage inspires us to challenge convention, ask bold questions and seek answers for them. Every day, we strive for excellence through our willingness to adapt, learn, and our tenacity to overcome barriers, together.

Opportunity Overview

Rhythm Pharmaceuticals is focused on making a positive impact on patients living with rare neuroendocrine diseases including rare genetic forms of obesity (RGDO).  This impact starts with providing patients and their families with a clear diagnosis.  As an Area Development Manager (ADM), you will play an integral role in building the RGDO community, to facilitate awareness, diagnosis, and care of patients.

You will work with cross functional teams to execute disease education and testing initiatives around RGDO and support the clinical development team on enrollment of clinical studies.  In this position you will report to the National Director of ADMs.  If you are a self-starter who enjoys working in patient-centric, dynamic environment, you will thrive in this role.

In this field-based role, you will be responsible for the following territory: CO, WA, OR, UT, KS, ID, WY, NM, NE, ND, SD, and AK. 

Responsibilities and Duties

•     Develop and effectively implement area business plans to achieve company objectives.  Execute a compliant, tailored approach by applying business analytics and marketplace knowledge.

•     Foster strong relationships with HCPs in assigned geography that lead to action.

•     Execute disease education to targeted HCPs in alignment with company priorities and direction.

•     Collaborate with cross functional teams, including clinical operations and MSLs, to optimize clinical study recruitment.

•     Support targeted population screenings in collaboration with HCPs & obesity networks.

•     Ensure accurate capture and reporting of data in the CRM.

•     Engage in ongoing training to improve skills and optimize execution to meet yearly objectives.

•     Collaborate with marketing teams on the development of collateral to support the teams’ activities.

•     Ensure completion of all corporate and administrative responsibilities with high level of efficiency, including healthcare compliance training, expense reports and other assignments by established deadlines.  

Qualifications and Skills

•     BS/BA degree in science or business preferred

•     6+ years of field experience as a sales or other related discipline in biotech or pharmaceutical industry

•     Rare disease experience is preferred

•     Ability to have a high command of scientific data and to communicate it effectively to different audiences

•     Excellent interpersonal and communication skills with a strong track record of customer engagement

•     Proven track record of execution that has delivered strong results, aligned with achievement of objectives

•     Demonstrates a passion for improving patient care delivery with strong customer orientation and insight

•     Demonstrated active listening skills applied to create relevant value to customers and key stakeholders

•     Self-motivated, highly energetic individual with the ability to adapt and thrive in a fast-paced and dynamic environment

•     Strong organizational and operational skills, with attention to details and sound business judgment

•     Strong understanding of healthcare regulatory and enforcement environments

•     Ability to travel up to 80% as necessary

This role is field-based. Candidates applying must be willing and able to travel frequently.

More About Rhythm

Our lead asset, IMCIVREE® (setmelanotide), is a precision medicine designed to treat hyperphagia, an insatiable, pathological hunger characterized by abnormal food-seeking behaviors, and early- or rapid-onset severe obesity caused by an impairment of a pathway in the hypothalamus called the melanocortin-4 receptor (MC4R) pathway. IMCIVREE® is the first and only approved therapy for certain rare MC4R pathway diseases in the United States, Europe, Great Britain and several other countries. In collaboration with leading experts across the world, Rhythm is advancing the most comprehensive clinical research program ever initiated in MC4R pathway diseases, including a Phase 3 trial for acquired hypothalamic obesity. In addition, we are leveraging our extensive genetic database, global network of researchers, a track record of regulatory successes and global commercial infrastructure to develop a full portfolio of treatment options to patients struggling with hyperphagia and severe obesity and ensuring they get the treatment that is right for them.

We continue to advance care and precision medicines that address rare diseases. We are focused on expanding access to IMCIVREE® to reach more patients and developing novel therapies for other rare neuroendocrine diseases, including congenital hyperinsulinism. Rhythm’s headquarters is in Boston, MA.  

Powered by JazzHR